Navigation Links
Microarray technology for tailoring breast cancer therapy

to adjuvant treatments. The researchers suggest that the technique of DNA microarray analysis could be developed to help breast cancer patients who do not benefit from adjuvant therapy, and avoid painful unnecessary treatments and wastage of healthcare resources.


'"/>

Source:Karolinska Institutet


Page: 1 2

Related biology news :

1. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
2. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
3. Breakthrough Microarray-based Technology for the Study of Cancer
4. Nanogen Issued Patent for Electronic Microarray With Memory
5. Characterizing Skin Cancer by Microarrays
6. Microarrays as phenotype
7. $6.5 Million Grant for Microarray Center at Yale School of Medicine
8. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
9. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
10. Novel technology detects human DNA mutations
11. Novel antiviral technology inhibits RSV infection in mice

Post Your Comments:
(Date:11/9/2009)...s inspired a 3.2m, three-year research project tha...security, energy and the environment. The Universi...QinetiQ have just signed a collaborative contract ...g physical sciences research. , Over the next t...y of Exeter and QinetiQ will work together to deve...
(Date:11/9/2009)...09 / b3c newswire / - Today, TNO, a Dutch contr...erican organization for contract research and cons... letter of intent with regard to TNOs dynamic in ...intent proposes a collaboration in which Seventh W...ion in North America. The TIM systems will be used...
(Date:11/9/2009)...leaders from around the world will gather in Bosto...ar Targets and Cancer Therapeutics International C...mation on important cancer therapies in developmen...it effectively we need a greater understanding of ...el," said Lewis Cantley, Ph.D., director of the ca...
Breaking Biology News(10 mins):£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Exponent to Announce Second Quarter 2009 Results 51709 1Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 1Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 2Elton John Billy Crystal Tony Bennett and Gladys Knight Help Starkey Hearing Foundation Raise More than 245 Million at Annual Fundraiser 51705 3Reminders Boost Mammography Appointments 51703 1Reminders Boost Mammography Appointments 51703 2
...ls have been little more than electronic versions ...the launch of PLoS ONE, which publishes primary re...pre- and post-publication peer review to maximize ...is published by the Public Library of Science (PLo...e the world,s scientific and medical literature a ...
...Many of them had narrow, pointed teeth, which were...wing them. But how did they then grind their food?... they were helped by stones which they swallowed. ...nd of ,gastric mill,. But this assumption does not...ties of Bonn and Tübingen have now proved. Their r...
... based on a combination of satellite data, compute...moke from Alaskan and Canadian forest fires as muc... away in Houston during a two-day period in July 2...in the Journal of Geophysical Research, offers sci...effects from pollutants generated thousands of mil...
Other Biology News:PLoS ONE is launched by the Public Library of Science 2PLoS ONE is launched by the Public Library of Science 3Dinosaurs -- stones did not help with digestion 2Dinosaurs -- stones did not help with digestion 3NASA study: Alaskan fires affected Houston air quality in 2004 2NASA study: Alaskan fires affected Houston air quality in 2004 3
(Date:11/6/2009)... 6 Calbiotech, Inc. announced toda...tive Research (SBIR) Phase I contract by the U.S. ...terms of the agreement, Calbiotech will develop an...f Dengue virus. ,, Dengue virus is a mosquit...o military forces deployed to tropical areas of th...
(Date:11/6/2009)...nda for Arrowhead’s 2010 Personalized Medici...lace on February 22-24, 2010 in Philadelphia, has ...ll highlight key issues in forming partnerships an...ces. , Minneapolis, MN (P...’s 2010 Personalized Medicine Partnerships ...
(Date:11/5/2009)...PRNewswire/ -- The endangered black-footed ferrets...is rare carnivore feeds on prairie dogs. The pra... entire population die-offs in towns occur. The U...ted a ferret breeding program and has been releasi...tive habitat. Unfortunately, plague can sweep thr...
(Date:11/5/2009).... 5 ThermoGenesis Corp. ... products for processing and storing adult stem ce...of fiscal 2010. ,, For the quarter ended Septem...2 million, a 15 percent increase over revenues of ...Company said the key contributors to the growth in...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...nference Call Tomorrow (Tuesday) at 8:30 am EDT to... Valley Cottage, NEW YORK, September 10 XTL,Biop...E: XTL) today announced,the initiation of a Phase ... norepinephrine reuptake inhibitor (SNRI) - for th...ine is being developed for the treatment of diabet...
...ltern, a leading global research,organization, is ...,Chiltern,s Country Manager for the Czech Republic...e year award. The award ceremony was held in,Londo...om amongst his peers by a panel of judges who,revi...ccessful conclusion,of clinical trials. The judgin...
Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
Other Biology Technology:XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 3XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 4XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 5XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 6XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 7Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year 2
...nity Life Sciences can provide custom microplate c...croplate processing equipment that dispenses and w...mmodate virtually any lot size of the following fo... 8 and 12 well strips, 96 well microplate, ...
Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
Mynox Mycoplasma Elimination Reagent from Minerva Biolabs GmbH
Mynox Mycoplasma Elimination Reagent from Sigma-Aldrich
Biology Products: